Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs

E-ISSN： 2212-3970|8|3|255-287

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.8, Iss.3, 2013-09, pp. : 255-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Ganoderma lucidum immunomodulatory protein modified with polyethylene glycol

Molecular Medicine Reports, Vol. 7, Iss. 3, 2013-01 ,pp. : 975-980

Spandidos Publications

Access to resources Recommend Favorite

Chalcone-Coumarin Derivatives as Potential Anti-Cancer Drugs: An in vitro and in vivo Investigation

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 7, 2014-09 ,pp. : 963-974

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-11 ,pp. : 1071-1080

Bentham Science Publishers

Access to resources Recommend Favorite

Trends in Biotechnological Drugs for Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 1, 2016-02 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite

Doxycycline as Potential Anti-cancer Agent

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 12, 2018-01 ,pp. : 1617-1623

Bentham Science Publishers

Access to resources Recommend Favorite